Page 4 - Philippe Menu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philippe menu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philippe Menu Today - Breaking & Trending Today

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

/PRNewswire/ SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,. ....

United States , Research Use , North America , Philippe Menu , Chief Medical Officer , Data Driven Medicine , Research Use Only , Sophia Genetics ,

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of ....

United States , Research Use , North America , Philippe Menu , Chief Medical Officer , Data Driven Medicine , Research Use Only , Looking Statements ,

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enroll 4,000 patients from approximately 30 sites across North America, Europe, and Latin America BOSTON and LAUSANNE, Switzerland, Dec.. ....

United States , Research Use , North America , Philippe Menu , Chief Medical Officer , Data Driven Medicine , Research Use Only , Looking Statements ,

SOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer

Share this article
Share this article
LAUSANNE, Switzerland and BOSTON, Feb. 8, 2021 /PRNewswire/ SOPHiA GENETICS, a global leader in Data-Driven Medicine, announced today a clinical research partnership initiative with the Spanish Lung Cancer Group to apply its radiomics and multimodal analysis capabilities to predict response to neoadjuvant chemoimmunotherapy in resectable stage IIIA non-small cell lung cancer (NSCLC).
SOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer
The collaboration with the Spanish Lung Cancer Group (Grupo Español de Cáncer de Pulmón GECP), a Spanish cooperative group for the research on lung cancer, is to show the potential of SOPHiA Radiomics a groundbreaking application that analyzes medical images for research use put to use in an additional retrospective analysis of the data from the phase 2 NADIM clinical ....

Mariano Provencio , Thierry Colin , Rita Perales , Bristol Myers Squibb , Sophie Reymond , European Union Horizon , Radiomics Research , Pr Communications , Smartest Companies , Spanish Lung Cancer Group , Spanish Lung Cancer Network , European Union , Lancet Oncology , Medical Oncology Department , Puerta De Hierro University Hospital , Philippe Menu , Chief Medical Officer , Data Driven Medicine , Spanish Lung Cancer , Sophia Genetics , தியரி கொலின் , ரீட்டா பெரலேச் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , சோஃபி ரேமண்ட் , ஐரோப்பிய தொழிற்சங்கம் அடிவானம் , ப்ர் தகவல்தொடர்புகள் ,